Insider Selling: Aveanna Healthcare (NASDAQ:AVAH) CAO Sells 11,962 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CAO Deborah Stewart sold 11,962 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total transaction of $93,901.70. Following the transaction, the chief accounting officer directly owned 251,676 shares of the company’s stock, valued at $1,975,656.60. This represents a 4.54% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Deborah Stewart also recently made the following trade(s):

• On Wednesday, December 31st, Deborah Stewart sold 11,275 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.18, for a total value of $92,229.50.
• On Tuesday, December 30th, Deborah Stewart sold 11,379 shares of Aveanna Healthcare stock. The stock was sold at an average price of $8.36, for a total value of $95,128.44.

Aveanna Healthcare Stock Down 1.1%

AVAH stock traded down $0.09 on Friday, reaching $8.08. 2,526,966 shares of the company traded hands, compared to its average volume of 1,076,101. The firm has a fifty day simple moving average of $8.92 and a 200-day simple moving average of $7.49. The company has a market cap of $1.69 billion, a P/E ratio of 22.44 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a one year low of $3.67 and a one year high of $10.32. The company has a debt-to-equity ratio of 140.39, a current ratio of 1.23 and a quick ratio of 1.23.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The firm had revenue of $450.53 million for the quarter. Research analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Zacks Research cut shares of Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a report on Monday, October 20th. UBS Group raised their price target on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a research report on Friday, November 7th. Raymond James Financial restated an “outperform” rating and issued a $13.00 price objective on shares of Aveanna Healthcare in a report on Friday, December 5th. Jefferies Financial Group increased their target price on Aveanna Healthcare from $11.00 to $12.50 and gave the company a “buy” rating in a research note on Tuesday, October 28th. Finally, William Blair started coverage on Aveanna Healthcare in a research note on Monday, December 8th. They issued an “outperform” rating for the company. Five analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $10.69.

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds have recently added to or reduced their stakes in AVAH. Banque Transatlantique SA bought a new position in shares of Aveanna Healthcare during the 1st quarter valued at $25,000. Quantbot Technologies LP purchased a new stake in Aveanna Healthcare during the second quarter valued at $43,000. Lion Street Advisors LLC purchased a new stake in Aveanna Healthcare during the third quarter valued at $89,000. Jump Financial LLC bought a new position in Aveanna Healthcare in the first quarter valued at about $59,000. Finally, Diversified Trust Co purchased a new position in Aveanna Healthcare in the second quarter worth about $57,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.